Astellas Pharma US products
AmBisome (amphotericin B liposomal) — Antifungal therapy for serious systemic fungal infections
Astagraf XL (tacrolimus extended-release) — Immunosuppression to prevent organ transplant rejection
Cresemba (isavuconazonium) — Treatment of invasive fungal infections
Izervay (avacincaptad pegol) — Prevents geographic atrophy in age-related macular degeneration
Lexiscan (regadenoson) — Pharmacologic stress agent for cardiac imaging
Myrbetriq (mirabegron) — Treatment of overactive bladder
Mycamine (micafungin) — Antifungal for systemic infections (echinocandin class)
Padcev (enfortumab vedotin) — Antibody-drug conjugate for urothelial cancer
Prograf (tacrolimus) — Standard immunosuppressive agent for transplant rejection prevention
Vesicare (solifenacin) — Overactive bladder management
Veoza / Veozah (fezolinetant) — Oral NK₃ antagonist for menopausal hot flashes
Vyloy (zolbetuximab) — First-line treatment of CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma
Xospata (gilteritinib) — FLT3-mutated acute myeloid leukemia therapy
Xtandi (enzalutamide) — Prostate cancer therapy (hormone-sensitive and metastatic settings)
No comments:
Post a Comment